CDC25C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.878820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.213200E-01
Normal-vs-Stage2
1.669000E-01
Normal-vs-Stage3
3.456000E-01
Normal-vs-Stage4
2.656800E-01
Stage1-vs-Stage2
5.143600E-01
Stage1-vs-Stage3
6.903200E-01
Stage1-vs-Stage4
8.362000E-01
Stage2-vs-Stage3
3.214000E-01
Stage2-vs-Stage4
7.838600E-01
Stage3-vs-Stage4
4.830400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.053200E-01
Normal-vs-AfricanAmerican
2.567200E-01
Normal-vs-Asian
2.876400E-02
Caucasian-vs-AfricanAmerican
7.081400E-01
Caucasian-vs-Asian
2.752200E-01
AfricanAmerican-vs-Asian
2.055000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.447980E-01
Normal-vs-Female
2.361000E-01
Male-vs-Female
6.774800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.703000E-01
Normal-vs-Age(41-60Yrs)
1.936430E-01
Normal-vs-Age(61-80Yrs)
1.656640E-01
Normal-vs-Age(81-100Yrs)
1.916810E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.644000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.725400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.787400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.857800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.027000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.048400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.036800E-01
Normal-vs-Daily Drinker
1.460610E-01
Normal-vs-Weekly Drinker
2.323400E-01
Normal-vs-Occasional Drinker
1.172400E-01
Normal-vs-Social Drinker
1.956190E-01
Non Drinker-vs-Daily Drinker
8.485000E-01
Non Drinker-vs-Weekly Drinker
9.191000E-01
Non Drinker-vs-Occasional Drinker
5.959800E-01
Non Drinker-vs-Social Drinker
8.583400E-01
Daily Drinker-vs-Weekly Drinker
7.643200E-01
Daily Drinker-vs-Occasional Drinker
6.939800E-01
Daily Drinker-vs-Social Drinker
9.724600E-01
Weekly Drinker-vs-Occasional Drinker
5.739200E-01
Weekly Drinker-vs-Social Drinker
7.762600E-01
Occasional Drinker-vs-Social Drinker
7.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.698600E-01
Normal-vs-Grade 2
6.655800E-01
Normal-vs-Grade 3
7.086600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.83422999999738E-05
Grade 1-vs-Grade 3
1.194040E-04
Grade 1-vs-Grade 4
5.698600E-01
Grade 2-vs-Grade 3
2.424400E-01
Grade 2-vs-Grade 4
6.655800E-01
Grade 3-vs-Grade 4
7.086600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.755200E-01
Normal-vs-NonDiabetic
1.708440E-01
Diabetic-vs-NonDiabetic
2.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.984300E-03
Normal-vs-NoPancreatitis
2.310800E-01
Pancreatitis-vs-NoPancreatitis
4.138100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.259370E-01
Normal-vs-N1
2.031600E-01
N0-vs-N1
9.683400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.616600E-03
Normal-vs-TP53-NonMutant
2.702200E-01
TP53-Mutant-vs-TP53-NonMutant
1.09589999963688E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
